Literature DB >> 2772702

Platelet function during the acute phase of dengue hemorrhagic fever.

T Srichaikul1, S Nimmannitya, T Sripaisarn, M Kamolsilpa, C Pulgate.   

Abstract

Platelet aggregation, plasma betathromboglobulin (BTG) and platelet factor 4 (PF4) were studied in 35 children with dengue hemorrhagic fever. The suppression of platelet aggregation was demonstrated during acute phase of DHF in both shock and non-shock patients. Simultaneous with abnormal platelet aggregation, there was increased release of BTG and PF4 from platelets into plasma during the acute phase which lasted only 3-4 days after shock or subsidence of fever. Acute phase plasma during DHF infection was also shown to have a stimulatory effect on the aggregation of autologous platelets. In this study we showed that there was an increase in platelet secretory activity of BTG and PF4 along with an impairment of the platelet aggregation during acute phase of DHF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2772702

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  17 in total

1.  The polymorphic landscape analysis of GATA1 exons uncovered the genetic variants associated with higher thrombocytopenia in dengue patients.

Authors:  Razoan Al Rimon; Mohammad Sayem; Saruar Alam; Abdullah Al Saba; Mousumi Sanyal; Md Robed Amin; Ahmedul Kabir; Sajib Chakraborty; A H M Nurun Nabi
Journal:  PLoS Negl Trop Dis       Date:  2022-06-30

Review 2.  Coronavirus Disease of 2019: a Mimicker of Dengue Infection?

Authors:  Joshua Henrina; Iwan Cahyo Santosa Putra; Sherly Lawrensia; Quinta Febryani Handoyono; Alius Cahyadi
Journal:  SN Compr Clin Med       Date:  2020-07-13

Review 3.  Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators.

Authors:  Elzinandes Leal de Azeredo; Robson Q Monteiro; Luzia Maria de-Oliveira Pinto
Journal:  Mediators Inflamm       Date:  2015-04-27       Impact factor: 4.711

Review 4.  Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer?

Authors:  Meera V Singh; Emily A Weber; Vir B Singh; Nicole E Stirpe; Sanjay B Maggirwar
Journal:  J Neurovirol       Date:  2017-01-23       Impact factor: 2.643

5.  Selective Tropism of Dengue Virus for Human Glycoprotein Ib.

Authors:  Nattapol Attatippaholkun; Nont Kosaisawe; Yaowalak U-Pratya; Panthipa Supraditaporn; Chanchao Lorthongpanich; Kovit Pattanapanyasat; Surapol Issaragrisil
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

Review 6.  Human platelets and their capacity of binding viruses: meaning and challenges?

Authors:  Adrien Chabert; Hind Hamzeh-Cognasse; Bruno Pozzetto; Fabrice Cognasse; Mirta Schattner; Ricardo M Gomez; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-04-28       Impact factor: 3.615

7.  Deadly intracranial bleed in patients with dengue fever: A series of nine patients and review of literature.

Authors:  Jo Ee Sam; Teak Sheng Gee; Abdul Wahab Nasser
Journal:  J Neurosci Rural Pract       Date:  2016 Jul-Sep

8.  Differential proteomic analysis of virus-enriched fractions obtained from plasma pools of patients with dengue fever or severe dengue.

Authors:  Romain Fragnoud; Marie Flamand; Frederic Reynier; Philippe Buchy; Vasna Duong; Alexandre Pachot; Glaucia Paranhos-Baccala; Frederic Bedin
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

9.  Multivariate time-series analysis of biomarkers from a dengue cohort offers new approaches for diagnosis and prognosis.

Authors:  Baptiste Vasey; Anuraj H Shankar; Bobby Brooke Herrera; Aniuska Becerra; Kris Xhaja; Marion Echenagucia; Sara R Machado; Diana Caicedo; John Miller; Paolo Amedeo; Elena N Naumova; Irene Bosch
Journal:  PLoS Negl Trop Dis       Date:  2020-06-16

Review 10.  Manipulation of cell surface macromolecules by flaviviruses.

Authors:  Robert Anderson
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.